Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - November 2023
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Podcasts
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Letters to the Editor
  • Collections
    • Back to parent navigation item
    • Collections
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
    • Interviews
    • Meetings reports
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Human Medicines
      • Medical Devices/IVDs
      • Veterinary Medicines
      • Annual Lecture
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Human Medicines
      • Medical Devices/IVDs
      • Veterinary Medicines
      • Annual Lecture
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Regulatory Rapporteur - November 2023
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Product information
      • Regulatory procedures
    • AdobeStock_628375803
      Access consortium: in the current submission transmission ecosystem
    • AdobeStock_540782876
      Controlled substances development – past, present, and future
    • North America
      Editorial - November 2023
  • Veterinary
    • Dog receiving flea treatment
      EMA activities related to antiparasitic veterinary medicinal products
    • North America
      Editorial - November 2023
    • AdobeStock_564278088
      SARS-CoV-2 can cause brain damage in dogs, says study
    • AdobeStock_552256917
      Autogenous vaccines under Regulation (EU) 2019/6
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • North America
      Editorial - November 2023
    • Med-Devices
      Medical device standards update
    • MedDevMat
      Optimal materials selection in medical device development – a proactive biocompatibility approach
  • Industry news
      • Industry news
        • Read latest news
        • Podcasts
        • Video
    • AdobeStock_565681691
      First three countries added to WHO-Listed regulatory agencies
    • NEWBORNBABY - AB
      Probiotic can boost immunity in children, study findings show
    • AdobeStock_627039942
      MHRA eligibility checker launched for IRP framework
  • Commentary
      • Editorials
      • Letters to the Editor
    • AdobeStock_585476774
      The worldwide web of regulation
    • RR-JUNE-2023-COVER
      Clinical trials:
      Ethical, ecological
      and economic change
    • Legalise-Cannabis
      Part 4. UK routes to registration for medicinal cannabis
  • Collections
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
      • Interviews
      • Meetings reports
      • Symposium 2022
        • Human Medicines
        • Medical Devices/IVDs
        • Veterinary Medicines
        • Annual Lecture
      • Symposium 2021
        • Human Medicines
        • Medical Devices/IVDs
        • Veterinary Medicines
        • Annual Lecture
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items

Combination Products Stories

  • AdobeStock_474265160

    What can past decision-making data tell us about how the FDA will make future combination product categorisation decisions?

    2022-05-26T11:04:00+01:00By Farha Sayeed

  • AdobeStock_405906571-min

    Practical insights into the recent EU MDR framework

    2022-04-18T13:18:00+01:00By Akhilesh Sharma, Dharti Shah, Pinki Mishra, Rakesh Suman, Shikha Tyagi, Nehal Bagga, Harika Potta, Karen Taylor-Worth, Suzie Ribeiro, Vesna Sevaljevic, Alyssa Schmidt, Stephanie Snow, Steve LoCastro, Vivek Tomar, Stuart Goodall

  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future focus topics
  • FAQs
  • Glossary
  • Privacy policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2023 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud